eTheRNA-A-002

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameeTheRNA-A-002
Drug Alias NameeTheRNA-A-002A-002
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSquamous Cell Carcinoma of Head and Neck
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGrand Pharmaceutical （China） Co LtdeTheRNA Immunotherapies NV
China Registration ClassN/A

Develop Information

Active CompanieseTheRNA Immunotherapies NVGrand Pharmaceutical （China） Co Ltd
Inactive CompaniesN/A
Active IndicationsSquamous Cell Carcinoma of Head and Neck
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A